Second Genome, Inc., a clinical-stage company focused on the development of novel therapeutics identified through microbiome science, today announced the appointment of Karim Dabbagh, Ph.D., as president, chief executive officer, and a member of the […]
The DuPont Microbiome Venture and Global Health & Nutrition Science teams have worked in collaboration with the University of Virginia and 4Pharma Ltd in an experimental rhinovirus challenge to understand the role of nasal microbiota clusters and their […]
Microbiome Insights was a founding partner of the Microbiome Skin Health and Dermatology conference —held September 10th to 12th, 2018. The aim of this event was to explore ways of understanding the mechanisms underlying microbial interactions […]
4D pharma plc (AIM: DDDD), a pharmaceutical company leading the development of live biotherapeutics, announced positive top-line results for its Phase Ib study of Thetanix in paediatric patients with Crohn’s disease. The study achieved its […]
The International Scientific Association for Probiotics and Prebiotics (ISAPP) has released a critique of two recent papers (here and here), which were published last week in the scientific journal Cell. The ISAPP Board of Directors, along […]
OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and skin care, announces the formation of a 100% owned subsidiary, ProBiotix Health Limited (“ProBiotix”), and appointment of Adam […]
uBiome recently raised $83 million in Series C financing, with OS Fund leading the round, and participation from 8VC, Y Combinator, Dentsu Ventures, as well as additional new and existing investors. “This is the next […]
Evolve BioSystems, makers of Evivo® baby probiotic, today unveiled its prototype for the first-ever rapid-response infant gut microbiome screening test. Using a small stool sample collected from a diaper the test will detect levels of […]
Indigo Ag, Inc., a company dedicated to harnessing nature to help farmers sustainably feed the planet, announces the launch of Indigo Marketplace™, along with the close of a $250M Series E funding round. Indigo Marketplace […]
Prescient Medicine Holdings, LLC and Metabiomics Corp., have announced a joint venture to develop an innovative microbiome diagnostics platform for detecting precancerous colon polyps and diagnosing other types of gastrointestinal diseases including Crohn’s, colitis (IBD), […]
Global demand exists for new ways to reduce antibiotic use, given the urgent public health threat of antibiotic resistance. A scientific paper published in European Journal of Public Health reports that those who take probiotics as […]